Tuesday, June 23, 2009

Biomarkers Predict Brain Tumor’s Response to Therapy

A report in Cancer Research, a journal of the American Association for Cancer Research, highlights a new biomarker that may be useful in identifying patients with recurrent glioblastoma, or brain tumors, who would respond better to anti-vascular endothelial growth factor therapy, specifically cediranib.

Link to full AACR release.

Sue McGreevey, smcgreevey@partners.org, 617 724-2764

Browse the Entire Newsroom Archive

Back to Top